Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 105% above its 5-year average of -2164.64%, near the high end of its 5-year range (-1013000.00%–17535.45%).
100.17% above its 12-month average of -59780.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
-59780.00%
GROSS MARGIN AVG 3Y
-574.51%
GROSS MARGIN AVG 5Y
-2164.64%
GROSS MARGIN AVG 10Y
-186.02%
GROSS MARGIN AVG 15Y
7.73%
GROSS MARGIN AVG 20Y
52.46%
CURRENT VS TTM AVG
+100.17%
CURRENT VS 3Y AVG
+117.41%
CURRENT VS 5Y AVG
+104.62%
CURRENT VS 10Y AVG
+153.76%
CURRENT VS 15Y AVG
+1193.05%
CURRENT VS 20Y AVG
+90.63%
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
+133.05%
vs the sector median at left
Altimmune, Inc.
Market Cap
$519.25M
Gross Margin
100.00%
TTM Avg
-59780.00%
3Y Avg
-574.51%
5Y Avg
-2164.64%
Market Cap
$517.79M
Gross Margin
100.00%
TTM Avg
50.00%
3Y Avg
75.00%
5Y Avg
83.33%
Market Cap
$517.73M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
-2215.86%
5Y Avg
-1460.58%
Market Cap
$547.86M
Gross Margin
87.05%
TTM Avg
84.77%
3Y Avg
78.39%
5Y Avg
75.97%
Market Cap
$551.09M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$487.30M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | $519.25M | 100.00% | -59780.00% | -574.51% | -2164.64% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | 100.00% | 50.00% | 75.00% | 83.33% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | 0.00% | 50.00% | -2215.86% | -1460.58% |
| Evolus, Inc. (EOLS)vs › | $491.93M | 66.25% | 66.66% | 65.82% | 64.54% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 42.92% | 41.39% | 40.24% | 40.24% |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 87.05% | 84.77% | 78.39% | 75.97% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 96.43% | 99.01% | 99.50% | 99.67% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.00% | 0.00% | 25.00% | 20.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | -299100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | -2040.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | -4979.56% |
| 2023-06-30 | -220783.33% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 17535.45% |
| 2022-09-30 | -1013000.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | -52662.50% |
| 2021-12-31 | -542.20% |
| 2021-09-30 | -18384.81% |
| 2021-06-30 | -9587.59% |
| 2021-03-31 | -1212.41% |
| 2020-12-31 | -548.83% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | -145.74% |
| 2019-12-31 | -277.40% |
| 2019-09-30 | -1255.59% |
| 2019-06-30 | -81.12% |
| 2019-03-31 | -8.87% |
| 2018-12-31 | -18.39% |
| 2018-09-30 | -79.50% |
| 2018-06-30 | -103.50% |
| 2018-03-31 | -116282.56% |
| 2017-12-31 | -58.78% |
| 2017-09-30 | -28.61% |
| 2017-06-30 | -106314.12% |
| 2017-03-31 | -246.50% |
| 2016-12-31 | -112.30% |
| 2016-09-30 | -141.57% |
| 2016-06-30 | 34.56% |
| 2016-03-31 | -5.66% |
| 2015-12-31 | -21.92% |
| 2015-09-30 | -42.44% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 100.00% |
| 2014-09-30 | 100.00% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | 100.00% |
| 2013-12-31 | 100.00% |
| 2013-09-30 | 100.00% |
| 2013-06-30 | 100.00% |
| 2013-03-31 | 100.00% |
| 2012-12-31 | 100.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 0.00% |
